{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-001386","form_type":"8-K","ticker":"GOVX","cik":"0000832489","company_name":"GeoVax Labs, Inc.","filed_at":"2024-01-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.025093+00:00","generated_at":"2026-06-06T23:41:13.299470+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"GeoVax shareholders approve authorized share reduction and reverse stock split","bullets":["Authorized shares reduced from 600M to 150M; vote: 11.2M for, 2.4M against.","Reverse stock split authorized at ratio of 1:5 to 1:15, Board to set ratio before Jan 31, 2024.","Approximately 51.8% of outstanding shares voted at special meeting on Jan 16, 2024.","Reverse split vote: 9.9M for, 3.6M against; no broker non-votes on either proposal."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-001386","json":"https://secwatch.observer/filing/0001437749-24-001386.json","markdown":"https://secwatch.observer/filing/0001437749-24-001386.md","text":"https://secwatch.observer/filing/0001437749-24-001386.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/832489/000143774924001386/0001437749-24-001386-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/832489/000143774924001386/govx20240116_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T23:41:13.299470+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"60de8807079aa7fb5bffb7b648fe7d3e6126b2b4","claim":"GeoVax Labs, Inc. shareholders approved Amendment to Certificate of Incorporation to reduce authorized shares of common stock from 600,000,000 to 150,000,000 at the 2024-01-16 meeting.","evidence_excerpt":"Reduction in Authorized Shares Our stockholders approved an amendment to our Certificate of Incorporation to reduce our authorized shares of common stock, $0.001 par value, from 600,000,000 to 150,000,000. There were no broker non-votes on this item. For Against Abstain 11,195,568 2,370,399 258,377","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924001386/0001437749-24-001386-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-01-16"}],"fact_type":"shareholder_vote"},{"claim_id":"8a803a78ffe9f20ffbc4f5beae9b59f1a13d4f50","claim":"GeoVax Labs, Inc. shareholders approved Amendment to Certificate of Incorporation to effect a reverse stock split of issued and outstanding common stock at a ratio of not less than 1-for-5 and not greater than 1-for-15, such ratio to be determined by the Board of Directors at any time prior to January 31, 2024 at the 2024-01-16 meeting.","evidence_excerpt":"Reverse Stock Split Our stockholders approved an amendment to our Certificate of Incorporation to effect a reverse stock split of our issued and outstanding common stock at a ratio of not less than 1-for-5 and not greater than 1-for-15, such ratio to be determined by our Board of Directors, at any time prior to January 31, 2024. There were no broker non-votes on this item. For Against Abstain 9,895,182 3,589,641 339,521","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/832489/000143774924001386/0001437749-24-001386-index.htm","confidence":0.95,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"charter amendment"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2024-01-16"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}